NBY Insider Trading

Insider Ownership Percentage: 1.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

NovaBay Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at NovaBay Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NovaBay Pharmaceuticals Share Price & Price History

Current Price: $0.08
Price Change: +0.30 (1.20%)
As of 04/17/2024 01:00 AM ET

This chart shows the closing price history over time for NBY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NovaBay Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/6/2022Audrey KuninInsiderSell1$1.81$1.81View SEC Filing Icon  
9/14/2022Jeffrey KuninInsiderSell291,368$0.16$46,618.88208,632View SEC Filing Icon  
9/14/2022Justin HallCEOBuy10,000$0.15$1,500.0083,172View SEC Filing Icon  
12/6/2021Andrew D JonesCFOBuy36,765$0.44$16,176.60View SEC Filing Icon  
12/6/2021Justin HallCEOBuy69,767$0.43$29,999.81View SEC Filing Icon  
12/3/2021Andrew D JonesCFOBuy8,690$0.44$3,823.60View SEC Filing Icon  
12/2/2021Jeffrey KuninInsiderBuy262,369$0.48$125,937.12View SEC Filing Icon  
11/30/2021Jeffrey KuninInsiderBuy30,000$0.46$13,800.00View SEC Filing Icon  
11/22/2021Audrey KuninInsiderBuy25,000$0.46$11,500.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NovaBay Pharmaceuticals (NYSEAMERICAN:NBY)

1.34% of NovaBay Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NovaBay Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2023Renaissance Technologies LLC44,923$34K0.0%+139.9%1.646%Search for SEC Filing on Google Icon
2/15/2023Armistice Capital LLC148,086$0.29M0.0%N/A7.894%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC17,423$34K0.0%-96.3%0.929%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP1,095,957$0.12M0.0%N/A1.686%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC409,544$0.10M0.0%+103.5%0.778%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC163,451$48K0.0%+260.4%0.311%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC201,222$60K0.0%+57.5%0.391%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC155,000$0.10M0.0%-52.3%0.370%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.485,033$0.33M0.0%+17.3%1.156%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP110,227$74K0.0%N/A0.263%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC31,364$29K0.0%-40.0%0.075%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC39,776$36K0.0%N/A0.095%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC147,318$0.13M0.0%+109.1%0.353%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP60,303$42K0.0%N/A0.144%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC400,393$0.28M0.0%-34.7%0.958%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC46,903$34K0.0%N/A0.112%Search for SEC Filing on Google Icon
12/1/2020Townsquare Capital LLC53,672$40K0.0%N/A0.128%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG23,460$27K0.0%+649.5%0.081%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC212,557$0.14M0.0%-38.8%0.762%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Read More on NovaBay Pharmaceuticals

Today's Range

Now: $0.08
Low: $0.08
High: $0.10

50 Day Range

MA: N/A

52 Week Range

Now: $0.08
Low: $0.07
High: $1.95

Volume

13,323,724 shs

Average Volume

3,462,818 shs

Market Capitalization

$349,009.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.82

Who are the company insiders with the largest holdings of NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals' top insider investors include:
  1. Jeffrey Kunin (Insider)
  2. Justin Hall (CEO)
  3. Audrey Kunin (Insider)
Learn More about top insider investors at NovaBay Pharmaceuticals.